XML 64 R44.htm IDEA: XBRL DOCUMENT
v3.20.2

Revenue Recognition - Schedule of Revenue by Product (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended
--- | --- | ---
Sep. 26, 2020 | Sep. 28, 2019 | Sep. 26, 2020 | Sep. 28, 2019
Disaggregation of Revenue [Line Items] |  |  |  |  |  |  |
Net sales | [1] | $ 1,213.7 | $ 1,191.1 | $ 3,773.8 |  | $ 3,514.6 |
CSCA |  |  |  |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |  |  |  |
Net sales |  | 664.0 | 613.3 | 1,992.2 | [2] | 1,777.2 | [2]
CSCA | Upper respiratory |  |  |  |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |  |  |  |
Net sales |  | 114.2 | 123.4 | 385.5 | [2] | 377.4 | [2]
CSCA | Digestive health |  |  |  |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |  |  |  |
Net sales |  | 107.1 | 85.0 | 326.1 | [2] | 293.6 | [2]
CSCA | Pain and sleep-aids |  |  |  |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |  |  |  |
Net sales |  | 100.6 | 89.4 | 318.7 | [2] | 272.0 | [2]
CSCA | Nutrition |  |  |  |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |  |  |  |
Net sales |  | 100.1 | 97.1 | 290.9 | [2] | 282.6 | [2]
CSCA | Healthy lifestyle |  |  |  |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |  |  |  |
Net sales |  | 86.1 | 87.9 | 253.4 | [2] | 250.0 | [2]
CSCA | Oral self-care |  |  |  |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |  |  |  |
Net sales |  | 81.1 | 54.2 | 199.6 | [2] | 54.2 | [2]
CSCA | Skincare and personal hygiene |  |  |  |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |  |  |  |
Net sales |  | 49.2 | 45.4 | 138.8 | [2] | 136.7 | [2]
CSCA | Vitamins, minerals, and supplements |  |  |  |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |  |  |  |
Net sales |  | 6.3 | 6.2 | 19.1 | [2] | 18.7 | [2]
CSCA | Animal health |  |  |  |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |  |  |  |
Net sales |  | 0.0 | 1.8 | 0.0 | [2] | 43.7 | [2]
CSCA | Other CSCA |  |  |  |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |  |  |  |
Net sales |  | 19.3 | 22.9 | 60.1 | [2],[3] | 48.3 | [2],[3]
CSCI |  |  |  |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |  |  |  |
Net sales |  | 339.0 | 347.5 | 1,042.8 |  | 1,025.8 |
CSCI | Upper respiratory |  |  |  |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |  |  |  |
Net sales |  | 62.3 | 72.1 | 191.9 |  | 193.9 |
CSCI | Digestive health |  |  |  |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |  |  |  |
Net sales |  | 6.8 | 5.3 | 17.9 |  | 19.3 |
CSCI | Pain and sleep-aids |  |  |  |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |  |  |  |
Net sales |  | 49.0 | 40.5 | 136.0 |  | 120.3 |
CSCI | Healthy lifestyle |  |  |  |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |  |  |  |
Net sales |  | 40.6 | 38.2 | 124.7 |  | 134.2 |
CSCI | Oral self-care |  |  |  |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |  |  |  |
Net sales |  | 25.2 | 24.3 | 68.8 |  | 27.7 |
CSCI | Skincare and personal hygiene |  |  |  |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |  |  |  |
Net sales |  | 83.1 | 88.9 | 275.4 |  | 296.5 |
CSCI | Vitamins, minerals, and supplements |  |  |  |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |  |  |  |
Net sales |  | 52.9 | 46.2 | 139.9 |  | 133.1 |
CSCI | Other CSCI |  |  |  |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |  |  |  |
Net sales |  | 19.1 | 32.0 | 88.2 | [4] | 100.8 | [4]
RX |  |  |  |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |  |  |  |
Net sales |  | $ 210.7 | $ 230.3 | $ 738.8 |  | $ 711.6 |
[1] | Derived from the location of the entity that sells to a third party.
[2] | Includes net sales from our OTC contract manufacturing business.
[3] | Consists primarily of diagnostic products and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.
[4] | Consists primarily of liquid licensed products, our distribution business and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 924 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=prgo_UpperRespiratoryMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=prgo_DigestiveHealthMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=prgo_PainandSleepaidsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=prgo_NutritionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=prgo_HealthyLifestyleMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=prgo_OralSelfcareMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=prgo_SkincareandPersonalHygieneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=prgo_VitaminsMineralsandSupplementsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=prgo_AnimalHealthMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=prgo_OtherCSCAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=prgo_OtherCSCIMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=prgo_RXPharmaceuticalsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |